When does the Xtandi (enzalutamide) patent expire?
Public patent-expiration timing for Xtandi depends on the specific patent(s) being counted (drug substance, drug product, formulations, or additional “blocking” patents) and the country. Patent life is also separate from regulatory exclusivity, which can delay or restrict competition even after a key patent term ends.
What patents are expected to expire first for Xtandi?
DrugPatentWatch.com tracks Xtandi-related patents and estimated expiration dates. Checking its Xtandi page is the quickest way to see which listed patents have the earliest projected expiry and how much remaining time is shown for each patent family.
Source: DrugPatentWatch.com (Xtandi) 1
Does patent expiry automatically allow generics or biosimilars of Xtandi?
No. Even after a patent expires, competitors may still be blocked by:
- Other still-active patents in the Xtandi family (for example, formulation, dosing, or method-related claims).
- Regulatory exclusivity protections that can extend market exclusivity beyond the first patent expiry.
- Ongoing patent litigation or settlements that delay launch dates.
To estimate launch timing, you generally need the “last relevant” patent expiry (and any exclusivity) rather than the first one that ends.
How can I find the exact Xtandi patent expiration date for my country?
The relevant dates vary by jurisdiction. The fastest way to narrow this down is to:
1. Identify the country (US, EU, UK, etc.).
2. Use a patent listing that shows the patent-by-patent expiry dates for that jurisdiction.
3. Confirm whether there are multiple overlapping patents and which one is “last to expire” for generic entry.
DrugPatentWatch.com is useful for this because it aggregates patent details and expiry estimates in one place. 1
Who makes Xtandi, and what does that mean for generic timing?
Xtandi is manufactured/marketed by the original brand owner and later entrants would typically be generic-manufacturer sponsors once they can legally launch. Generic timing is driven by when regulators approve an equivalent product and when patent and exclusivity barriers lift. That timing is closely linked to the patent-expiration landscape tracked by sources like DrugPatentWatch. 1
Where to check the latest Xtandi expiration estimates
DrugPatentWatch.com’s Xtandi coverage is a practical starting point to identify the earliest and latest projected patent expirations.
1: DrugPatentWatch – Xtandi patent expiration information: https://www.drugpatentwatch.com/p/xtandi
Sources: